99
Views
12
CrossRef citations to date
0
Altmetric
Original article: Clinical

Retreatment with yttrium-90 ibritumomab tiuxetan in patients with B-cell non-Hodgkin's lymphoma

, , , , , , , , , , , , , , , , , , , , & show all
Pages 1736-1744 | Received 19 Mar 2007, Accepted 20 Jun 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matthew S McKinney & Anne W Beaven. (2014) Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 45-59.
Read now
Martina Lehnert, Heinz Ludwig & Niklas Zojer. (2009) Update on the rational use of 90Y-ibritumomab tiuxetan in the treatment of follicular lymphoma. OncoTargets and Therapy 2, pages 199-208.
Read now

Articles from other publishers (10)

Mahsa Eskian, MirHojjat Khorasanizadeh, Pier L Zinzani & Nima Rezaei. (2018) Radioimmunotherapy as the first line of treatment in non-Hodgkin lymphoma. Immunotherapy 10:8, pages 699-711.
Crossref
Michael Tomblyn. (2012) Radioimmunotherapy for B-Cell Non-Hodgkin Lymphomas. Cancer Control 19:3, pages 196-203.
Crossref
Michael F. Leahy & J. Harvey Turner. (2011) Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients. Blood 117:1, pages 45-52.
Crossref
Robert M. Sharkey, Habibe Karacay & David M. Goldenberg. (2010) Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides. Cancer 116:S4, pages 1134-1145.
Crossref
Umberto Vitolo, Giovanni Barosi, Stefano Fanti, Alessandro M. Gianni, Maurizio Martelli, Mario Petrini, Pier Luigi Zinzani & Sante Tura. (2010) Consensus conference on the use of 90‐yttrium‐ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology. American Journal of Hematology 85:2, pages 147-155.
Crossref
Sui Shen, Andres Forero, Ruby F. Meredith, Jatin J. Shah, Susan J. Knox, Gregory A. Wiseman, Marc E. Usrey & Albert F. LoBuglio. (2010) Impact of Rituximab Treatment on 90 Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma . Journal of Nuclear Medicine 51:1, pages 150-157.
Crossref
Robert M. Sharkey, Oliver W. Press & David M. Goldenberg. (2009) A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy. Blood 113:17, pages 3891-3895.
Crossref
N. Rizzo-Padoin. (2008) Apport de la radio-immunothérapie au traitement des lymphomes. Annales Pharmaceutiques Françaises 66:5-6, pages 300-308.
Crossref
M.J. Bishton, M.F. Leahy, R.J. Hicks, J.H. Turner, A.D. McQuillan & J.F. Seymour. (2008) Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab. Annals of Oncology 19:9, pages 1629-1633.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:2, pages 115-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.